Scan Mode | Ultra Helical |
Collimation | 0.5mm x 80 |
kVp | 120 |
mAs | SUREExposure |
Rotation Time | 0.5s |
Scan Range | 465.0mm |
Reconstruction | AiCE Body |
CTDlvol | 15.5mGy |
DLP | 733.2mGy·cm |
Effective Dose | 10.9mSv |
k-factor | 0.015 (AAPM Report 96) |
Scan Mode | Ultra Helical |
Collimation | 0.5mm x 80 |
kVp | 120 |
mAs | SUREExposure |
Rotation Time | 0.35s |
Scan Range | 421.0mm |
Reconstruction | AiCE Body Sharp |
CTDlvol | 9.2mGy |
DLP | 431.4mGy·cm |
Effective Dose | 6.4mSv |
k-factor | 0.015 (AAPM Report 96) |
Use AiCE Lung in low dose chest imaging for reduced noise and improved detail of lung parenchyma on COVID-19 positive patients.
View Scan ParametersScan Mode | Ultra Helical |
Collimation | 0.5mm x 80 |
kVp | 10 |
mAs | SUREExposure |
Rotation Time | 0.35s |
Scan Range | 325.0mm |
Reconstruction | AiCE Body Sharp |
CTDlvol | 2.1mGy |
DLP | 77.2mGy·cm |
Effective Dose | 1.0mSv |
k-factor | 0.014 (AAPM Report 96) |
A vHP, Aortic CTA scan demonstrates an endovascular stent graft repair placed in the aortic arch.
HR 67–92 bpm
Scan Mode | vHP |
Collimation | 0.5mm x 40 |
HP | 15.6 – 111.0 |
kVp | 100 |
mAs | SUREExposure |
Rotation Time | 0.35s |
Scan Range | 646.5mm |
Reconstruction | AIDR 3D |
CTDlvol | 11.4mGy |
DLP | 787.20mGy·cm |
Effective Dose | 11.4mSv |
k-factor | 0.0145 (AAPM Report 96) |
AiCE DLR demonstrating excellent visualisation of subtle Ground-Glass Opacity and Emphysematous changes, through low-noise and high-resolution characteristics.
View Scan ParametersScan Mode | Ultra Helical |
Collimation | 0.5mm x 80 |
kVp | 120 |
mAs | EC |
Rotation Time | 0.5s |
Scan Range | 388.0mm |
Reconstruction | AiCE Lung |
CTDlvol | 9.1mGy |
DLP | 392.5mGy·cm |
Effective Dose | 5.7mSv |
k-factor | 0.014 (AAPM Report 96) |
A three-phase liver protocol was completed. The iodine maps demonstrate liver masses. A low attenuation lesion is seen on the left kidney.
View Scan Parameters (Non-Contrast)Scan Mode | Ultra-Helical |
Collimation | 0.5mm x 80 |
kVp | 120 |
mAs | SUREExposure |
Rotation Time | 0.5s |
Scan Range | 252.0mm |
Reconstruction | AIDR 3D |
CTDlvol | 7.1mGy |
DLP | 211.6mGy·cm |
Effective Dose | 3.17mSv |
k-factor | 0.015 (AAPM Report 96) |
Scan Mode | Ultra-Helical |
Collimation | 0.5mm x 80 |
kVp | 120 |
mAs | SUREExposure |
Rotation Time | 0.5s |
Scan Range | 255.0mm |
Reconstruction | AIDR 3D |
CTDlvol | 7.1mGy |
DLP | 213.3mGy·cm |
Effective Dose | 3.19mSv |
k-factor | 0.015 (AAPM Report 96) |
Scan Mode | Ultra-Helical |
Collimation | 0.5mm x 80 |
kVp | 120 |
mAs | SUREExposure |
Rotation Time | 0.5s |
Scan Range | 450.0mm |
Reconstruction | AIDR 3D |
CTDlvol | 6.2mGy |
DLP | 306.5mGy·cm |
Effective Dose | 4.49mSv |
k-factor | 0.015 (AAPM Report 96) |
An ultra-low dose, non-contrast lung CT scan was performed with AIDR 3D. Effective dose 0.02 mSv
View Scan ParametersScan Mode | Helical |
Collimation | 1.0mm x 40 |
kVp | 80 |
mAs | 3 |
Rotation Time | 0.35s |
Scan Range | 314.4mm |
Reconstruction | AIDR 3D |
CTDlvol | 0.0mGy |
DLP | 1.7mGy·cm |
Effective Dose | 0.02mSv |
k-factor | 0.014 (AAPM Report 96) |
A SURESubtraction Runoff CTA was performed to evaluate peripheral arteries.
View Scan Parameters (Pre-contrast)Scan Mode | Ultra-Helical |
Collimation | 0.5mm x 80 |
kVp | 100 |
mAs | SUREExposure |
Rotation Time | 0.35s |
Scan Range | 1383.0mm |
Reconstruction | AIDR 3D |
CTDlvol | 2.3mGy |
DLP | 332.7mGy·cm |
Scan Mode | Ultra-Helical |
Collimation | 0.5mm x 80 |
kVp | 100 |
mAs | SUREExposure |
Rotation Time | 0.35s |
Scan Range | 1383.0mm |
Reconstruction | AIDR 3D |
CTDlvol | 2.8mGy |
DLP | 396.3mGy·cm |
3D and MPR demonstrate spinal fixation with reduced metal artifact due to SEMAR.
View Scan ParametersScan Mode | Ultra-Helical |
Collimation | 0.5mm x 80 |
kVp | 80 |
mAs | SUREExposure |
Rotation Time | 0.5s |
Scan Range | 429.0mm |
Reconstruction | AIDR 3D |
Metal Artifact Reduction | SEMAR |
CTDlvol | 4.7mGy |
DLP | 223.1mGy·cm |
Effective Dose | 3.34mSv |
k-factor | 0.015 (AAPM Report 96) |
Abdominal aorta CTA performed with AIDR 3D
View Scan ParametersScan Mode | Ultra-Helical |
Collimation | 0.5mm x 80 |
kVp | 100 |
mAs | SUREExposure |
Rotation Time | 0.5s |
Scan Range | 495.0mm |
Reconstruction | AIDR 3D |
CTDlvol | 4.3mGy |
DLP | 232.7mGy·cm |
Effective Dose | 3.4mSv |
k-factor | 0.015 (AAPM Report 96) |
CTA with AIDR 3D demonstrates advanced atherosclerotic changes in the tortuous aorta and extensive intimal hemorrhage.
View Scan ParametersScan Mode | Ultra-Helical |
Collimation | 0.5mm x 80 |
kVp | 100 |
mAs | SUREExposure |
Rotation Time | 0.5s |
Scan Range | 697.8mm |
Reconstruction | AIDR 3D |
CTDlvol | 6.6mGy |
DLP | 491.4mGy·cm |
Effective Dose | 7.1mSv |
k-factor | 0.0145 (AAPM Report 96) |
Abdominal delayed phase CT scan demonstrates left ureteral leak.
View Scan ParametersScan Mode | Ultra-Helical |
Collimation | 0.5mm x 80 |
kVp | 120 |
mAs | SUREExposure |
Rotation Time | 0.5s |
Scan Range | 420.0mm |
Reconstruction | AIDR 3D |
CTDIvol | 9.5mGy |
DLP | 443.3mGy·cm |
Effective Dose | 6.64mSv |
k-factor | 0.015 (AAPM Report 96) |
Dual-Energy analysis to evaluate kidney stones composed of uric acid.
View Scan ParametersScan Mode | DE-Helical |
Collimation | 0.5mm x 80 |
kVp | 135/80 |
mAs | 50/290 |
Rotation Time | 0.5s |
Scan Range | 44.5mm |
Reconstruction | AIDR 3D |
CTDlvol | 12.1mGy |
DLP | 61.2mGy·cm |
Effective Dose | 0.92mSv |
k-factor | 0.015 (AAPM Report 96) |
The information on this website is not intended for consumers. It is directed exclusively for healthcare professionals and persons who are engaging in purchasing or the business of wholesaling therapeutic goods (in accordance with the Therapeutic Goods Advertising Code Instrument 2021).
By selecting “Continue” you are indicating that you are the intended audience. Click “Cancel” to be redirected to the Canon Medical Systems global website.
© Canon Medical Systems ANZ Pty Limited.
© Canon Medical Systems ANZ Pty Limited.